Evidence map›Paper›PMID 32915058›Full record

ArticleAnnals of the American Thoracic Society2021

Epidemiology and Healthcare Utilization of Spontaneous Pneumothorax and Diffuse Cystic Lung Diseases in the United States.

Ashley Cattran, Karthikeyan Meganathan, Nishant Gupta

Abstract readLetter
In one paragraph

Article in Annals of the American Thoracic Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ashley CattranUniversity of Cincinnati Cincinnati, Ohio.
Karthikeyan MeganathanUniversity of Cincinnati Cincinnati, Ohio.
Nishant GuptaUniversity of Cincinnati Cincinnati, Ohio.ORCID 0000-0001-9112-1315

Funding

Resveratrol and Sirolimus in LAM Trial (RESULT)R34HL138235 · NHLBI · UNIVERSITY OF CINCINNATI · PI GUPTA, NISHANT · 2017 to 2019
$712k
NHLBI NIH HHS R34 HL138235
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lung DiseasesPneumothoraxHumansPatient Acceptance of Health CareUnited States

Identifiers

PMID32915058
PMCPMC7919158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.